H.C Wainwright Initiates Coverage - BUY

***On May 14, H.C. Wainwright increased their target to $23!***


On January 13, 2020,  H.C. Wainwright initiates coverage On CEL-SCI to Buy with a PT of $18. 

298 HAS HAPPENED!!!!

CEL-SCI announced that their nearly 10 year trial has finally ended.  The 298th event (death) recently occurred.  May the ones who have perished to this terrible disease find peace.  


We expect a few things to occur:

  • Large Funds and investors finally jumping in.
  • Share price to accelerate over the coming 3-5 weeks and may touch $25 before top line results are released!
  • Target price is $200 with successful data.

IDMC SAYS CONTINUE!!!!

 The IDMC made the following recommendation on April 23, 2020:


  • The IDMC recommendation “agrees with continuing the trial without change”.


READ ABOUT THE IDMC HERE

CEL-SCI IS HIRING!!!!!!!

Why is a small  Biotech with limited cash resources hiring manufacturing  positions? Why would they incur the costs to hire, train and pay new employees at this juncture?


Per the recent Zacks article, they have already hired 7 employees since 1/1/20 and are now looking to add 4 more!


This is not normal...This is BULLISH!!!!!


READ ABOUT IT HERE

Commercial Scale Preparation Has Begun!

In the PR accompanying the 10-Q, the CEO, Geert Kersten, dropped a BOMB!


 "We are therefore preparing for commercial scale production of Multikine at our manufacturing facility,” stated CEL-SCI CEO, Geert Kersten. 

****INSIDER BUYS****

 "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise." - Peter Lynch 


On 2/26, 6 insiders purchased shares after the attempted "take down" by those Nasty Shorts!  


On 1/13, Geert buys another $50K! (hint hint. wink wink)


On 10/25, Geert bought another $25K!


On 9/4, the Geert and 2 others purchased another $57K. 


On  6/3,  Geert  bought  MORE!  He  bought  another $25K


On 5/7,  Geert "purchased another $100,000 worth of restricted CEL-SCI stock at $6.86 directly from the Company at the full market price. Several others from our senior management team and one member of the Board of Directors have joined  Geert and purchased another $110,000 worth of CEL-SCI stock on the same terms. "


Furthermore, on 5/21 Peter Young bought another $10K on the open market.


All Insider Transactions can be seen here.

CNBC'S JIM CRAMER DISCUSSES CEL-SCI, AGAIN!!!!!

On February 4th, CNBC's Jim Cramer AGAIN gives another ***BUY*** for CVM!!!


 "This is one I'm in favor of, even up here."  


This is the second time in 4 months!


Why Has CVM Hired Lobbyists?

Why has CEL-SCI contracted with The Petrizzo Group to lobby the FDA/US Government about "FDA approval issues of innovative drug therapies"?


Why spend $150K when cash flow is low?


They lobbied the U.S. Senate, the U.S. House of Reps, the FDA, the Office of Management and Budget and Health & Human Services.


This ain't cheap. They have spent $50K for the last 3 quarters. Latest LD-2 form here.

9/25: ERGOMED SAYS STUDY IS 96% COMPLETE OR DID THEY??

On 9/25, Ergomed released their Interim financial results.  In this presentation, they state the following:


  •  Awaiting Phase III results 
  •  Limited work ongoing on 30 day terms and paid from share sales 
  • 96% complete  


96% complete...not 95% or "First Half of 2019" (like their prior presentation), but 96%.  Why not 95%?


This implies we are at 286 Events!  FOSCO is RIGHT!!!!


******BUT WAIT!!!  Shortly after posting this all over the internet, the Interim Presentation was REMOVED and UPDATED.  It no longer mentions "96% Complete".  


Don't worry, your pal Sushi kept a copy here!


Why did they remove 96%?  Because they fucked up and accidentally released CONFIDENTIAL info.  That's why!


READ THE AMAZING ARTICLE BELOW

Our 15 Minutes of Fame

Aren't we something?  Watch this video talking all about this site!